Broad-spectrum caspase inhibitors: from myth to reality?
Chauvier
D
D
Ankri
S
S
Charriaut-Marlangue
C
C
Casimir
R
R
Jacotot
E
E
D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D061945:Caspase Inhibitors; D002403:Cathepsins / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D051379:Mice; D009474:Neurons / Q000187:drug effects / Q000201:enzymology; D011804:Quinolines / Q000494:pharmacology
D000590:Amino Acid Chloromethyl Ketones; D001593:Benzyl Compounds; C476029:Boc-D-FMK; D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors; D006845:Hydrocarbons, Fluorinated; D011804:Quinolines; C096713:benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone; C468548:quinoline-val-asp(OMe)-CH2-OPH; D002403:Cathepsins